Senate Finance Committee Chairman Wyden Expands Big Pharma Tax Investigation With Pfizer Inquiry
May 22, 2024
May 22, 2024
WASHINGTON, May 22 -- Sen. Ron Wyden, D-Oregon, chairman of the Senate Finance Committee, issued the following news release:
Senate Finance Committee Chair Ron Wyden, D-Ore., expanded his ongoing investigation into Big Pharma's tax avoidance and profit shifting with a new letter sent on Monday to the CEO of Pfizer. An analysis by the Finance Committee of Pfizer's SEC filings found that the company's effective tax rate fell by 75 percent following the passage of the Trump tax law in . . .
Senate Finance Committee Chair Ron Wyden, D-Ore., expanded his ongoing investigation into Big Pharma's tax avoidance and profit shifting with a new letter sent on Monday to the CEO of Pfizer. An analysis by the Finance Committee of Pfizer's SEC filings found that the company's effective tax rate fell by 75 percent following the passage of the Trump tax law in . . .